Healthcare provider profile · identity verified

Bryan Lee Sowell, M.D.

Family Practice · SAN BERNARDINO, CA · NPI 1306896691

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	805	272
Amlodipine Besylate	Amlodipine Besylate	451	164
Metformin Hcl	Metformin Hcl	426	136
Lisinopril	Lisinopril	425	145
Losartan Potassium	Losartan Potassium	294	99
Pantoprazole Sodium	Pantoprazole Sodium	294	112
Omeprazole	Omeprazole	274	97
Hydrochlorothiazide	Hydrochlorothiazide	263	79
Gabapentin	Gabapentin	217	64
Levothyroxine Sodium	Levothyroxine Sodium	215	58
Tamsulosin Hcl	Tamsulosin Hcl	190	74
Simvastatin	Simvastatin	186	56
Albuterol Sulfate Hfa	Albuterol Sulfate	178	46
Fluticasone Propionate	Fluticasone Propionate	168	72
Furosemide	Furosemide	162	56
Glipizide	Glipizide	160	57
Metoprolol Tartrate	Metoprolol Tartrate	139	45
Carvedilol	Carvedilol	128	37
Ibuprofen	Ibuprofen	121	57
Metoprolol Succinate	Metoprolol Succinate	117	39
Benazepril Hcl	Benazepril Hcl	111	35
Alendronate Sodium	Alendronate Sodium	110	38
Eliquis	Apixaban	110	24
Jardiance	Empagliflozin	98	32
Clonidine Hcl	Clonidine Hcl	90	27
Allopurinol	Allopurinol	88	21
Tramadol Hcl	Tramadol Hcl	86	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	34
Atenolol	Atenolol	84	27
Diclofenac Sodium	Diclofenac Sodium	81	41
Clopidogrel	Clopidogrel Bisulfate	73	22
Trazodone Hcl	Trazodone Hcl	71	29
Chlorthalidone	Chlorthalidone	67	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	22
Pioglitazone Hcl	Pioglitazone Hcl	63	21
Glimepiride	Glimepiride	61	19
Januvia	Sitagliptin Phosphate	61	13
Nifedipine Er	Nifedipine	60	16
Finasteride	Finasteride	59	24
Lantus	Insulin Glargine,hum.Rec.Anlog	58	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	17
Farxiga	Dapagliflozin Propanediol	56	15
Ozempic	Semaglutide	56	12
Donepezil Hcl	Donepezil Hcl	55	18
Rosuvastatin Calcium	Rosuvastatin Calcium	53	19
Duloxetine Hcl	Duloxetine Hcl	52	17
Enalapril Maleate	Enalapril Maleate	51	14
Baclofen	Baclofen	46	18
Synthroid	Levothyroxine Sodium	46	14
Lovastatin	Lovastatin	43	16
Sertraline Hcl	Sertraline Hcl	43	12
Triamcinolone Acetonide	Triamcinolone Acetonide	42	24
Pravastatin Sodium	Pravastatin Sodium	41	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	15
Potassium Chloride	Potassium Chloride	39	15
Meloxicam	Meloxicam	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Sildenafil Citrate	Sildenafil Citrate	36	14
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	34	14
Alprazolam	Alprazolam	34	12
Naproxen	Naproxen	33	14
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Hydrocortisone	Hydrocortisone	31	11
Hydralazine Hcl	Hydralazine Hcl	27	12
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Azithromycin	Azithromycin	24	19
Mirtazapine	Mirtazapine	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Insulin Lispro	Insulin Lispro	22	suppressed
Cephalexin	Cephalexin	21	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Famotidine	Famotidine	20	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Nitroglycerin	Nitroglycerin	18	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Naloxone Hcl	Naloxone Hcl	17	16
Terazosin Hcl	Terazosin Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	11
Glipizide-Metformin	Glipizide/Metformin Hcl	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	12
Prednisone	Prednisone	15	suppressed
Primidone	Primidone	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Piroxicam	Piroxicam	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error